The rising influence of several major medication firms is raising grave concerns globally. This trend towards monopolies often results to increased drug charges, restricted development, and challenges in receiving essential medications for patients in the globe. Analysts suggest that more robust regulation is required to tackle these problems and g

India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These traditional companies, including organizati